Citations

Clear

16281 citation(s) found for "Yu, David".

Do systolic BP and pulse pressure relate to ventricular enlargement?
Graff‐Radford, Neill R. , Penman, Alan D. , Coker, Laura H., Knopman, David S. , Mosley, Thomas H.

Mayo Clinic

European Journal of Neurology | January 7, 2013 | Volume: 20 | Issue: 4 | Pages: 720-724

10.1111/ene.12067 | PMID 23294486 Get It

Background and purposeTo evaluate the association between systolic, diastolic and pulse pressure, and increase in ventricular size (VS). Observations in laboratory animals suggest intraventricular pulse pressure (systolic–diastolic) may play a role in ventricular enlargement.MethodsInitial magnetic resonance (MR) scans and vascular risk factors evaluation were performed in 1812 Atherosclerosis Risk in Communities participants in 1994–1995. In 2004–2006, 1130 participants underwent repeat MR. VS was rated using a validated nine‐point scale. Multiple logistic regression analysis assessed association between blood pressure measures and pulse pressure, and the change between the MR scans of VS controlling for age, sex and race.ResultsAt baseline 1112 participants (385 black women, 200 black men, 304 white women and 223 white men) had a mean age of 61.7 ± 4.3 years. In adjusted models pulse pressure at baseline was associated with an increase in VS [odds ratio (OR) 1.19, 95% confidence interval (CI) 1.01–1.40], as was systolic pressure (OR 1.28, 95% CI 1.03–1.58).ConclusionsSystolic pressure and pulse pressure are associated with future development of increased VS. The findings are consistent with the animal literature that increased pulse pressure predisposes to risk of future increased VS. High pulse pressure might play a role in the pathogenesis of normal pressure hydrocephalus.
HLA Class II Molecules Influence Susceptibility versus Protection in Inflammatory Diseases by Determining the Cytokine Profile
Mangalam, Ashutosh K. , Taneja, Veena , David, Chella S., Taneja, Veena

Mayo Clinic

The Journal of Immunology | January 4, 2013 | Volume: 190 | Issue: 2 | Pages: 513-518

10.4049/jimmunol.1201891 | PMID 23293357 Get It

Abstract The MHC in humans encodes the most polymorphic genes, the HLA genes, which are critical for the immune system to clear infection. This can be attributed to strong selection pressure as populations moved to different parts of the world and encountered new kinds of infections, leading to new HLA class II alleles. HLA genes also have the highest relative risk for autoimmune diseases. Three haplotypes, that is, HLA-DR2DQ6, DR4DQ8, and DR3DQ2, account for HLA association with most autoimmune diseases. We hypothesize that these haplotypes, along with their multiple subtypes, have survived bottlenecks of infectious episodes in human history because of their ability to present pathogenic peptides to activate T cells that secrete cytokines to clear infections. Unfortunately, they also present self-peptides/mimics to activate autoreactive T cells secreting proinflammatory cytokines that cause autoimmune diseases.
Shining a light on posterior cortical atrophy
Crutch, Sebastian J. , Schott, Jonathan M. , Rabinovici, Gil D. , Cappa, Stefano F. , Dubois, Bruno , Graff‐Radford, Neill R., Krolak‐Salmon, Pierre , Lehmann, Manja , Mendez, Mario F. , Pijnenburg, Yolande A.L. , Ryan, Natalie S. , Scheltens, Philip , Shakespeare, Timothy J. , Tang‐Wai, David F. , Flier, Wiesje M. van der , Bain, Lisa J. , Carrillo, María C. , Fox, Nick C. , Boeve, Bradley F. , Dickerson, Bradford Clark , Graff‐Radford, Neill R., van der Flier, Wiesje M , Scheltens, Philip , Fox, Nick C , Rabinovici, Gil D , Schott, Jonathan M , Pijnenburg, Yolande A L

Mayo Clinic

Alzheimer's & Dementia | December 28, 2012 | Volume: 9 | Issue: 4 | Pages: 463-465

10.1016/j.jalz.2012.11.004 | PMID 23274153 Get It

Abstract Posterior cortical atrophy (PCA) is a clinicoradiologic syndrome characterized by progressive decline in visual processing skills, relatively intact memory and language in the early stages, and atrophy of posterior brain regions. Misdiagnosis of PCA is common, owing not only to its relative rarity and unusual and variable presentation, but also because patients frequently first seek the opinion of an ophthalmologist, who may note normal eye examinations by their usual tests but may not appreciate cortical brain dysfunction. Seeking to raise awareness of the disease, stimulate research, and promote collaboration, a multidisciplinary group of PCA research clinicians formed an international working party, which had its first face‐to‐face meeting on July 13, 2012 in Vancouver, Canada, prior to the Alzheimer's Association International Conference.
Biallelic Deleterious BRCA1 Mutations in a Woman with Early-Onset Ovarian Cancer
Tang, Jiang-bo, Stopfer, Jill E. , Lilli, Dana R., Hamel, Nancy , Monteiro, Álvaro N.A. , Messick, Troy E. , Powers, Jacquelyn M. , Yonker, Alexandria, Goldgar, David E., Davidson, H. Rosemarie, Nathanson, Katherine L. , Domchek, Susan M. , Tischkowitz, Marc D. , Couch, Fergus J. , Foulkes, William D. , Greenberg, Roger A. , Monteiro, Alvaro N , Nathanson, Katherine L

Mayo Clinic

Cancer Discovery | December 26, 2012 | Volume: 3 | Issue: 4 | Pages: 399-405

10.1158/2159-8290.cd-12-0421 | PMID 23269703 Get It

Abstract BRCA1 and BRCA2 are the most important breast and ovarian cancer susceptibility genes. Biallelic mutations in BRCA2 can lead to Fanconi anemia and predisposition to cancers, whereas biallelic BRCA1 mutations have not been confirmed, presumably because one wild-type BRCA1 allele is required during embryogenesis. This study describes an individual who was diagnosed with ovarian carcinoma at age 28 and found to have one allele with a deleterious mutation in BRCA1, c.2457delC (p.Asp821Ilefs*25), and a second allele with a variant of unknown significance in BRCA1, c.5207T>C (p.Val1736Ala). Medical records revealed short stature, microcephaly, developmental delay, and significant toxicity from chemotherapy. BRCA1 p.Val1736Ala cosegregated with cancer in multiple families, associated tumors showed loss of wild-type BRCA1, and BRCA1 p.Val1736Ala showed reduced DNA damage localization. These findings represent the first validated example of biallelic deleterious human BRCA1 mutations and have implications for the interpretation of genetic test results. Significance: Accurate assessment of genetic testing data for BRCA1 mutations is essential for clinical monitoring and treatment strategies. Here, we report the first validated example of an individual with biallelic BRCA1 mutations, early-onset ovarian cancer, and clinically significant hypersensitivity to chemotherapy. Cancer Discov; 3(4); 399–405. ©2012 AACR. See related commentary by D'Andrea, p. 376 This article is highlighted in the In This Issue feature, p. 363
Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene
Keaveny, Tony M. , Kopperdahl, David L. , Wermers, Robert A. , Wan, Xiaohai, Krohn, Kelly, Krege, John H. , Cosman, Felicia

Mayo Clinic

Journal of Bone and Mineral Research | December 22, 2012 | Volume: 28 | Issue: 6 | Pages: 1328-1336

10.1002/jbmr.1853 | PMID 23281041 Get It

ABSTRACT Many postmenopausal women treated with teriparatide for osteoporosis have previously received antiresorptive therapy. In women treated with alendronate (ALN) or raloxifene (RLX), adding versus switching to teriparatide produced different responses in areal bone mineral density (aBMD) and biochemistry; the effects of these approaches on volumetric BMD (vBMD) and bone strength are unknown. In this study, postmenopausal women with osteoporosis receiving ALN 70 mg/week (n = 91) or RLX 60 mg/day (n = 77) for ≥18 months were randomly assigned to add or switch to teriparatide 20 µg/day. Quantitative computed tomography scans were performed at baseline, 6 months, and 18 months to assess changes in vBMD; strength was estimated by nonlinear finite element analysis. A statistical plan specifying analyses was approved before assessments were completed. At the spine, median vBMD and strength increased from baseline in all groups (13.2% to 17.5%, p < 0.01); there were no significant differences between the Add and Switch groups. In the RLX stratum, hip vBMD and strength increased at 6 and 18 months in the Add group but only at 18 months in the Switch group (Strength, Month 18: 2.7% Add group, p < 0.01 and 3.4% Switch group, p < 0.05). In the ALN stratum, hip vBMD increased in the Add but not in the Switch group (0.9% versus –0.5% at 6 months and 2.2% versus 0.0% at 18 months, both p ≤ 0.004 group difference). At 18 months, hip strength increased in the Add group (2.7%, p < 0.01) but not in the Switch group (0%); however, the difference between groups was not significant (p = 0.076). Adding or switching to teriparatide conferred similar benefits on spine strength in postmenopausal women with osteoporosis pretreated with ALN or RLX. Increases in hip strength were more variable. In RLX-treated women, strength increased more quickly in the Add group; in ALN-treated women, a significant increase in strength compared with baseline was seen only in the Add group.
Intrinsic microvasculature of the sciatic nerve in the rat
Zamir, M. , Twynstra, Jasna , Vercnocke, Andrew J. , Welch, Ian, Jorgensen, Steve M., Ritman, Erik L., Holdsworth, David W. , Shoemaker, J. Kevin , Jorgensen, Steven M., Shoemaker, J Kevin

Mayo Clinic

Journal of the Peripheral Nervous System | December 22, 2012 | Volume: 17 | Issue: 4 | Pages: 377-384

10.1111/j.1529-8027.2012.00435.x | PMID 23279338 Get It

AbstractMicrovasculature associated with the sciatic nerve was examined using high‐resolution micro‐CT scanning in one group of rats and surgical exploration in another. The results indicate that blood supply to the sciatic nerve is an “open‐ended” system in which the vessels run longitudinally within the epineurium and connect with external vasculature primarily at junction points. Although the range of vasculature found extended down to 4–5 μ, only a few isolated vessels of this size were found, with no capillary “mesh” as such, possibly because of the close proximity of the intrinsic vessel to nerve fibers within the epineurium. While the study did not include direct measurements of flow or nerve function, the “open‐ended” pattern of vasculature found has important implications regarding the relationship between the two. Specifically, the nerve is less vulnerable to a severe or complete disruption in blood supply than it would be under a close‐ended system such as that of the heart or brain, where a severe disruption can occur with the obstruction of only a single vessel. Indeed, the pattern of vasculature found, subject to further study of vasculature at the capillary level, suggests that flow within the intrinsic vessels may be in either direction, depending on circumstances, somewhat like flow within the circle of Willis in the cerebral circulation.
Use of Compliance Measures in an Analysis of the Effect of Diltiazem on Mortality and Reinfarction After Myocardial Infarction
Oakes, David , Moss, A.J., Fleiss, Joseph L., Bigger, J. Thomas, Therneau, TM, Eberly, Shirley , Manatunga, Amita K. , Carleen, Eric, Benhorin, Jesaia, Post-Infa, The Multicenter Diltiazem, McDermott, Michael P. , McDermott, Michael

Mayo Clinic

Journal of the American Statistical Association | December 20, 2012 | Volume: 88 | Issue: 421 | Pages: 44-49

10.1080/01621459.1993.10594287 Get It

Prospective feasibility study on the use of multiband mucosectomy for endoscopic resection of early squamous neoplasia in the esophagus
Boerwinkel, David F., He, Siyi , Weusten, Bas L. , Fleischer, David E., Lü, Ning , Zuo, Sasa , Dou, L., Zhang, Yu , Xue, Liyan , Dawsey, Sanford M. , Qin, Xianhui , Dou, L., Bergman, Jacques , Wang, Guomin

Mayo Clinic

Endoscopy | December 20, 2012 | Volume: 45 | Issue: 03 | Pages: 167-173

10.1055/s-0032-1326011 | PMID 23258547 Get It

Outcomes of Cardiac Resynchronization Therapy in the Elderly
Killu, Ammar M. , WU, JIA‐HUI, Friedman, Paul A. , Shen, Win-Kuang, Webster, Tracy L., Brooke, Kelly L., Hodge, David O. , Wiste, Heather J. , Cha, Yong‐Mei

Mayo Clinic

Pacing and Clinical Electrophysiology | December 18, 2012 | Volume: 36 | Issue: 6 | Pages: 664-672

10.1111/pace.12048 | PMID 23252710 Get It

BackgroundOctogenarians (>80 years) have been underrepresented in clinical trials of cardiac resynchronization therapy (CRT).ObjectiveTo determine the benefit of CRT with or without a defibrillator in older elderly patients.MethodsWe retrospectively studied consecutive patients who received CRT at our institution from 2002 through 2008. New York Heart Association (NYHA) class and echocardiographic parameters were assessed before and after CRT. Thirty‐day complications after device implant were collected. Survival data were obtained from the national death and location database. Data were compared between those 80 years and younger and those older than 80 years.ResultsOf 728 patients identified, 90 (12.4%) were older than 80 years. After CRT, older and younger patients had similar improvements in NHYA class (P = 0.41), ejection fraction (P = 0.48), and mitral valve regurgitation (MR) severity (P = 0.42). In the older patients, defibrillator implantation was associated with comparable improvement in NYHA class, ejection fraction, and MR grade severity (P > 0.05), as in those without a defibrillator. Overall survival was worse in octogenarians than in the younger patients by Kaplan‐Meier estimates (P = 0.001). Multivariate analysis showed similar survival between the younger and older subjects (hazard ratio, 1.23; 95% confidence interval, 0.83–1.84; P = 0.31). The observed complication rate in all study subjects was 12.2%, with no difference between the two age groups.ConclusionOctogenarian patients who received CRT with or without a defibrillator for advanced heart failure had similar clinical benefits as younger patients. CRT should not be withheld from octogenarians meeting current selection guidelines.
Overcoming Barriers to Addressing Education Problems With Research Design: A Panel Discussion
Yarris, Lalena M. , Gruppen, Larry D. , Hamstra, Stanley J. , Ericsson, K. Anders , Cook, David A. , Hamstra, Stanley J

Mayo Clinic

Academic Emergency Medicine | December 18, 2012 | Volume: 19 | Issue: 12 | Pages: 1344-1349

10.1111/acem.12025 | PMID 23252365 Get It

AbstractA plenary panel session at the 2012 Academic Emergency Medicine consensus conference “Education Research in Emergency Medicine: Opportunities, Challenges, and Strategies for Success” discussed barriers educators face in imagining, designing, and implementing studies to address educational challenges. This proceedings article presents a general approach to getting started in education research. Four examples of studies from the medical education literature that illustrate a distinct way to approach specific research questions are discussed. The study designs used are applicable to a variety of education research problems in emergency medicine (EM). Potential applications of studies are discussed, as well as effects and lessons learned.